Welcome to chemicalbook!
400-158-6606
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook >> CAS DataBase List >> Unii-0789652qul

Unii-0789652qul

Unii-0789652qul price.
  • $128 - $795
  • Product name: Unii-0789652qul
  • CAS: 130112-42-4
  • MF: C12H14N2O3S3
  • MW: 330.45
  • EINECS:
  • MDL Number:MFCD02752797
  • Synonyms:Ccris 8109;Isopropyl 2-(1,3-dithietane-2-ylidine)-2-(N-(4-methyl-2-thiazol-2-yl)carbamoyl)acetate;Mivotilate;Mivotilate [inn];Unii-0789652qul;2-(1,3-Dithietan-2-ylidene)-3-[(4-methyl-2-thiazolyl)amino]-3-oxo-propanoic acid 1-methylethyl ester;Isopropyl-2-(1,3-dithietane-2-ylidene)-2[N-(4-methyl2-thiazol-2-yl)carbamoyl] acetate;Propanoic acid, 2-(1,3-dithietan-2-ylidene)-3-[(4-methyl-2-thiazolyl)amino]-3-oxo-, 1-methylethyl ester
8 prices
Selected condition:
Brand
  • American Custom Chemicals Corporation
  • ChemScene
  • CSNpharm
  • Sigma-Aldrich
Package
  • 1mg
  • 5MG
  • 10mg
  • 25mg
  • ManufacturerAmerican Custom Chemicals Corporation
  • Product numberCHM0295004
  • Product description2-(1,3-DITHIETAN-2-YLIDENE)-3-[(4-METHYL-2-THIAZOLYL)AMINO]-3-OXO-PROPANOIC ACID-1-METHYLETHYL ESTER 95.00%
  • Packaging5MG
  • Price$504.53
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-0018393
  • Product descriptionMivotilate >98.0%
  • Packaging5mg
  • Price$450
  • Updated2021-12-16
  • Buy
  • ManufacturerChemScene
  • Product numberCS-0018393
  • Product descriptionMivotilate >98.0%
  • Packaging10mg
  • Price$750
  • Updated2021-12-16
  • Buy
  • ManufacturerCSNpharm
  • Product numberCSN22230
  • Product descriptionMivotilate
  • Packaging1mg
  • Price$128
  • Updated2021-12-16
  • Buy
  • ManufacturerCSNpharm
  • Product numberCSN22230
  • Product descriptionMivotilate
  • Packaging5mg
  • Price$383
  • Updated2021-12-16
  • Buy
  • ManufacturerCSNpharm
  • Product numberCSN22230
  • Product descriptionMivotilate
  • Packaging10mg
  • Price$638
  • Updated2021-12-16
  • Buy
  • ManufacturerSigma-Aldrich
  • Product numberY1646
  • Product descriptionYH439 ≥98% (HPLC)
  • Packaging5mg
  • Price$165
  • Updated2024-03-01
  • Buy
  • ManufacturerSigma-Aldrich
  • Product numberY1646
  • Product descriptionYH439 ≥98% (HPLC)
  • Packaging25mg
  • Price$795
  • Updated2023-01-07
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
American Custom Chemicals Corporation CHM0295004 2-(1,3-DITHIETAN-2-YLIDENE)-3-[(4-METHYL-2-THIAZOLYL)AMINO]-3-OXO-PROPANOIC ACID-1-METHYLETHYL ESTER 95.00% 5MG $504.53 2021-12-16 Buy
ChemScene CS-0018393 Mivotilate >98.0% 5mg $450 2021-12-16 Buy
ChemScene CS-0018393 Mivotilate >98.0% 10mg $750 2021-12-16 Buy
CSNpharm CSN22230 Mivotilate 1mg $128 2021-12-16 Buy
CSNpharm CSN22230 Mivotilate 5mg $383 2021-12-16 Buy
CSNpharm CSN22230 Mivotilate 10mg $638 2021-12-16 Buy
Sigma-Aldrich Y1646 YH439 ≥98% (HPLC) 5mg $165 2024-03-01 Buy
Sigma-Aldrich Y1646 YH439 ≥98% (HPLC) 25mg $795 2023-01-07 Buy

Properties

Density :1.467±0.06 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: ≥5mg/mL
form :solid
pka :4.89±0.70(Predicted)
color :Light yellow to yellow

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Mivotilate is an orally-active hepatoprotective agent introduced for the treatment of liver cirrhosis and hepatitis-B infection. It is a dithietanylidene malonate analogue of malotilate and is without the haemotological adverse effects associated with the latter. Mivotilate can be obtained by partial saponification of the corresponding diisopropylmalonate, conversion of the acid function into mixed anhydride then to the amide with an aminothiazole. It displays potent hepatoprotective activity in rat and mice liver injury models by a mechanism involving the inactivation of Kupffer cells. Mivotilate was shown to exert multiple effects on the hepatic cytochrome P450 system, particularly to inhibit CYP2E1 expression and to up-regulate the CYP1A1 expression. The low oral bioavailability of Mivotilate in rats (F<0.22%) could be primarilly attributed to poor absorption and considerable hepatic and gastrointestinal first-pass effects. Mivotilate prevents mutagenesis caused by agents such as benzo[a]pyrene and reduces skin tumors induced by these agents.